In contrast to the immunocompetent setting, F127ZIF‐8AB680 did not show a significant effect on restraining EGFR mutant LLC tumors in the mature T cell‐lacking nude mice in vivo (Figure S15, Supporting Information), suggesting that its anti‐tumor capacity is mainly dependent on regulation of the adaptive immunity. The gene discussed is EGFR; the disease is neoplasm.